Goldman Sachs Group Inc. Buys 1,782 Shares of RTI Surgical, Inc. (RTIX)

Goldman Sachs Group Inc. lifted its stake in RTI Surgical, Inc. (NASDAQ:RTIX) by 2.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 87,767 shares of the medical equipment provider’s stock after purchasing an additional 1,782 shares during the quarter. Goldman Sachs Group Inc. owned about 0.15% of RTI Surgical worth $513,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of RTIX. Cigna Investments Inc. New acquired a new stake in shares of RTI Surgical in the second quarter valued at approximately $105,000. Citigroup Inc. increased its holdings in shares of RTI Surgical by 2,850.1% in the second quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock valued at $124,000 after purchasing an additional 20,435 shares during the last quarter. First Quadrant L P CA acquired a new stake in RTI Surgical during the second quarter worth $137,000. American International Group Inc. increased its stake in RTI Surgical by 7.0% during the first quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock worth $141,000 after acquiring an additional 2,327 shares during the last quarter. Finally, Thompson Davis & CO. Inc. increased its stake in RTI Surgical by 138.8% during the second quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock worth $147,000 after acquiring an additional 14,577 shares during the last quarter. 68.55% of the stock is owned by hedge funds and other institutional investors.

Several equities research analysts have issued reports on the company. BidaskClub cut RTI Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th. Zacks Investment Research raised RTI Surgical from a “sell” rating to a “hold” rating in a research note on Friday, October 13th.

Shares of RTI Surgical, Inc. (NASDAQ:RTIX) opened at $4.75 on Monday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.21 and a current ratio of 3.34. The stock has a market capitalization of $288.95, a price-to-earnings ratio of 118.75, a price-to-earnings-growth ratio of 6.33 and a beta of 1.73. RTI Surgical, Inc. has a one year low of $2.70 and a one year high of $6.00.

RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. The company had revenue of $66.69 million during the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The company’s revenue for the quarter was up .2% on a year-over-year basis. equities analysts expect that RTI Surgical, Inc. will post 0.05 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://www.themarketsdaily.com/2017/11/13/goldman-sachs-group-inc-buys-1782-shares-of-rti-surgical-inc-rtix.html.

In other RTI Surgical news, Director Nicholas J. Valeriani bought 5,500 shares of the business’s stock in a transaction on Monday, August 21st. The stock was bought at an average price of $4.70 per share, with a total value of $25,850.00. Following the completion of the purchase, the director now directly owns 47,754 shares in the company, valued at $224,443.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 4.90% of the stock is owned by company insiders.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Institutional Ownership by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply